Topics:

Rheumatology Network

Rheumatology Network went to Disney World this month, to learn what's most important to pediatric rheumatology in 2014. Watch for our latest and forthcoming reports on important sessions from ACR's PRSYM, including:

Long View of Childhood Lupus Outcomes

New Criteria Set for Pediatric Rheumatology

... and updates from the Childhood Arthritis & Rheumatology Alliance (CARRA), and more.

Recent Content

A new guidance document from the FDA attempts to define in detail when two monoclonal antibodies are the same. It says it will not use this definition for biosimilars, but only for "orphan drugs."

The FDA has issued a safety alert warning that epidural corticosteroid injections may rarely cause serious neurological adverse events including loss of vision, stroke or paralysis, or may be fatal.

Medication adherence among gout patients is poorer than for many other chronic conditions. Authors of a systematic review point to some probable explanations.

British rheumatology experts have proposed guidelines for managing adults with ANCA-associated vasculitides (AAVs) -- granulomatosis with polyangiitis (GPA), eosinophilic granulomatosis with polyangiitis, and microscopic polyangiitis.

New reviews discuss the neurobiology of fibromyalgia, assessing the best treatment options, both pharmaceutical and behavioral.

(ACR Pediatrics 2014) Children growing into young adults with rheumatic diseases often fail to get the care they need, for numerous complicated reasons. The ACA could change all this, with implications for adult rheumatologists. Here, a brief look at the situation and some solutions.

To "Thunder God Vine" from China, add fish oil and gluten-free diets as alternative remedies for rheumatoid arthritis. What is the evidence? Here, a review plus commentary from an expert.

Please Wait 20 seconds or click here to close